We are live on ! Find out more
MAM

MPM Asset Management Portfolio holdings

AUM $44.5M
1-Year Est. Return 47.28%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
-47.28%
3 Year Est. Return
+5.89%
5 Year Est. Return
-18.52%
10 Year Est. Return
+3.53%
AUM
$234M
AUM Growth
-$13.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYTM icon
1
Rhythm Pharmaceuticals
RYTM
$7.07B
$66.4M 28.41%
3,074,893
HARP
2
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$61.8M 26.45%
452,443
TCRR
3
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$60.9M 26.06%
4,050,865
CHMA
4
DELISTED
Chiasma, Inc. Common Stock
CHMA
$28.4M 12.15%
5,736,296
SNDX icon
5
Syndax Pharmaceuticals
SNDX
$1.84B
$16.2M 6.93%
2,168,691

Similar funds

MPM Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, MPM Asset Management held 5 positions worth $234M, down 5.6% from $247M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 0%. MPM Asset Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MPM Asset Management's ten largest holdings make up 100% of its $234M portfolio in Q3 2019.
  • MPM Asset Management opened 0 new positions and closed 0 in Q3 2019.
  • MPM Asset Management's portfolio value fell 5.6% quarter-over-quarter to $234M.

Based on MPM Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.